Expression of McI-1 in mantle cell lymphoma is associated with high-grade morphology, a high proliferative state, and p53 overexpression

Journal of Pathology

Volumn 199, Issue 1, 2003, Pages 90-97

  Khoury, Joseph D ^a   Medeiros, L Jeffrey ^a   Rassidakis, George Z ^a   McDonnell, Timothy J ^a   Abruzzo, Lynne V ^a   Lai, Raymond ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Apoptosis; Ki 67; Mantle cell lymphoma; McI 1; p53; Proliferation; TUNEL

Indexed keywords

ANTIMITOTIC AGENT; KI 67 ANTIGEN; PROTEIN MCL 1; PROTEIN P53; MCL1 PROTEIN; PROTEIN BCL 2; TUMOR PROTEIN;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; CANCER GRADING; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FREQUENCY ANALYSIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOCYTOMA; MALE; MANTLE CELL LYMPHOMA; MITOSIS INHIBITION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION; TUMOR CLASSIFICATION; WESTERN BLOTTING; APOPTOSIS; CELL CULTURE; CELL DIVISION; METABOLISM; METHODOLOGY; MIDDLE AGED; NICK END LABELING; PATHOLOGY; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BLOTTING, WESTERN; CELL DIVISION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037207516     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1254     Document Type: Article

References (44)

1. Swerdlow SH, Berger F, Isaacson PI, et al. Mantle cell lymphoma. In World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). IARC Press: Lyon, 2001; 168-170.
2. Weisenburger DD. Mantle cell lymphoma. In Neoplastic Hematopathology (2nd edn), Knowles DM (ed.). Lippincott Williams and Wilkins: Philadelphia, 2001; 789-803.
3. Campo E, Raffeld M, Jaffe ES. Mantle-cell lymphoma. Semin Hematol 1999; 36: 115-127.
4. Sherr CJ. Cancer cell cycles. Science 1996; 274: 1672-1677.
5. Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 2000; 60: 3689-3695.
6. Pinyol M, Hernandez L, Cazorla M, et al. Deletions and loss of expression of p16 INK4 and p21 Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Blood 1997; 86: 272-280.
7. Quintanilla-Martinez L, Thieblemont C, Fend F, et al. Mantle cell lymphomas lack expression of p27kip1, a cyclin-dependent kinase inhibitor. Am J Pathol 1998; 153: 175-182.
8. Chiarle R, Budel LM, Skolnik J, et al. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Blood 2000; 95: 619-626.
9. Greiner TC, Moynihan MJ, Chan WC, et al. P53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood 1996; 87: 4302-4310.
10. Hernandez L, Fest T, Cazorla M, et al. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood 1996; 87: 3351-3359.
11. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 1994; 13: 2124-2130.
12. Lovec H, Grzeschiczek A, Kowalski MB, Moroy T. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J 1994; 13: 3487-3495.
13. Ott MM, Bartkova J, Bartek J, et al. Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity. Blood 1997; 90: 3154-3159.
14. Hofmann WK, de Vos S, Tsukasaki K, et al. Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. Blood 2001; 98: 787-794.
15. Hermann M, Scholman HJ, Maratioti T, Stein H, Schriever F. Differential expression of apoptosis, Bcl-x and c-Myc in normal and malignant lymphoid tissues. Eur J Haematol 1997; 59: 20- 30.
16. Clodi K, Snell V, Zhao S, Cabanillas F, Andreeff M, Younes A. Unbalanced expression of Fas and CD40 in mantle cell lymphoma. Br J Haematol 1998; 103: 217-219.
17. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci U S A 1993; 90: 3516-3520.
18. Reynolds JE, Li J, Craig RW, Eastman A. BCL-2 and Mcl-1 expression in Chinese hamster ovary cells inhibits intracellular acidification and apoptosis induced by staurosporine. Exp Cell Res 1996; 225: 430-436.
19. Lomo J, Smeland EB, Krajewski S, Reed JC, Blomhoff HK. Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes. Cancer Res 1996; 56: 40-43.
20. Zhou P, Qian L, Kozopas KM, Craig RW. Mcl-1 a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood 1997; 89: 630-643.
21. Chao JR, Wang JM, Lee SF, et al. Mcl-1 is an immediate-early gene activated by the granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling pathway and is one component of the GM-CSF viability response. Mol Cell Biol 1998; 18: 4883-4898.
22. Puthier D, Bataille R, Amiot M. IL-6 up-regulates Mcl-1 in human myeloma cells through JAK/STAT rather than ras/MAP kinase pathway. Eur J Immunol 1999; 29: 3945-3950.
23. Wei LH, Kuo ML, Chen CA, et al. The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by upregulation of Mcl-1 through a PI 3-K/Akt pathway. Oncogene 2001; 20: 5799-5809.
24. Huang HM, Huang CJ, Yen JJ. Mcl-1 is a common target of stem cell factor and interleukin-5 for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt pathways. Blood 2000; 96: 1764-1771.
25. Zhan Q, Bieszczad CK, Bae I, Fornace AJ Jr, Craig RW. Induction of BCL2 family member MCL1 as an early response to DNA damage. Oncogene 1997; 14: 1031-1039.
26. Fujise K, Zhang D, Liu J, Yeh ETH. Regulation of apoptosis and cell cycle progression by MCLI. Differential role of proliferating cell nuclear antigen. J Biol Chem 2000; 275: 39458-39465.
27. Zhou P, Levy NB, Xie H, et al. MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. Blood 2001; 97: 3902-3909.
28. Jeon HJ, Kim CW, Yoshino T, Akagi T. Establishment and characterization of a mantle cell lymphoma cell line. Br J Haematol 1998; 102: 1323-1326.
29. Lai R, McDonnell TJ, O'Conner SL, et al. Establishment and characterization of a new mantle cell lymphoma cell line, MINO. Leuk Res 2002; 26: 849-855.
30. Rassidakis GZ, Sarris AH, Herling M, et al. Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage. Am J Pathol 2001; 159: 527-535.
31. Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M, Reed JC. Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol 1994; 145: 515-525.
32. Krajewski S, Bodrug S, Krajewska M, et al. Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol 1995; 146: 1309-1319.
33. Li L, Krajewski S, Reed JC, Choi YS. The apoptosis and proliferation of SAC-activated B cells by IL-10 are associated with changes in Bcl-2, Bcl-xL, and Mcl-1 expression. Cell Immunol 1997; 178: 33-41.
34. Lomo J, Blomhoff HK, Jacobsen SE, Krajewski S, Reed JC, Smeland EB. Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-xL and Mcl-1 Blood 1997; 89: 4415-4424.
35. Kuo ML, Chuang SE, Lin MT, Yang SY. The involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6. Oncogene 2001; 20: 677-685.
36. Wang JM, Chao JR, Chen W, Kuo ML, Yen JJ, Yang-Yen HF. The antiapoptotic gene Mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB. Mol Cell Biol 1999; 19: 6195-6206.
37. Yang T, Buchan HL, Townsend KJ, Craig RW. Mcl-1, a member of the Bcl-2 family, is induced rapidly in response to signals for cell differentiation or death, but not to signals for cell proliferation. J Cell Physiol 1996; 166: 523-536.
38. Ando T, Shibata H, Suzuki T, et al. The possible role of apoptosis-suppressing genes, bcl-2 and Mcl-1/EAT in human adrenal tumors. Endocr Res 1998; 24: 955-960.
39. Miyamoto Y, Hosotani R, Wada M, et al. Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in pancreatic cancers. Oncology 1999; 56: 73-82.
40. Boucher MJ, Morisset J, Vachon PH, Reed JC, Laine J, Rivard N. MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. J Cell Biochem 2000; 79: 355-369.
41. Krajewska M, Krajewski S, Epstein JI, et al. Imnumohistochemical analysis of bcl-2, bax, bcl-X, and Mcl-1 expression in prostate cancers. Am J Pathol 1996; 148: 1567-1576.
42. Tang L, Tron VA, Reed JC, et al. Expression of apoptosis regulators in cutaneous malignant melanoma. Clin Cancer Res 1998; 4: 1865-1871.
43. Epling-Burnette PK, Liu JH, Catlett-Falcone R, et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 2001; 107: 351-362.
44. Moulding DA, Giles RV, Spiller DG, White MR, Tidd DM, Edwards SW. Apoptosis is rapidly triggered by antisense depletion of Mcl-1 in differentiating U937 cells. Blood 2000; 96: 1756-1763.